
|Videos|December 11, 2020
Management of high-risk NMIBC: Options for treatment expand
Author(s)Urology Times staff
“As urologists, we all need to start speaking in risk stratification criteria,” says Katie Murray, DO.
Advertisement
In this video, Katie Murray, DO, shares her takeaways from a discussion at the 2020 Society of Urologic Oncology annual meeting titled, Optimizing Management of High Risk NMIBC – Case-Based Discussion, for which she served as a panelist. Murray is an assistant professor of surgery-urology at the University of Missouri, Columbia.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5











